Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Research & Development Medical research

Deep Research Down Under

| Rich Whitworth

Meet the Wizards of Oz in a mini tour of The Lambert Initiative for Cannabinoid Therapeutics, University of Sydney, Australia – featuring Director Iain McGregor and other key members of the team who are all pushing cannabis and cannabinoid research to the next level.

Business & Profession Legislation & policy

A United Kingdom on Cannabis?

| Rich Whitworth

Project Twenty21 (T21) – the UK’s first medical cannabis registry – is building evidence to support prescription of cannabis. Meanwhile, cannabis consultancy firm Maple Tree publish 10 recommendations for the UK government to improve access and build a valuable medical cannabis market.

Research & Development Medical research

Found in Translation

| Rich Whitworth

Ziva Cooper, Director of the UCLA Cannabis Research Initiative, explores the biggest question(s) left in cannabis research and discusses how her own research bridges the gap between animal literature and human behavior...

Register to personalize your newsfeed

Create Account

Latest Articles

Testing & Processing Tools & technology

Cannabis testing - are you involved?

| Sponsored by LGC Group

If you are currently involved in cannabis testing, we would be very grateful if you would complete our short survey

Research & Development Pharmaceutical

We Need a Bigger Fence

| Rich Whitworth

When it comes to (medical) cannabis, why all the side picking?

Business & Profession Legislation & policy

Protagonist or Supporting Act?

| Tomas Skrinskas

Medical cannabis is not a blockbuster drug – the plant should be considered as just one component of an overall therapy or regimen

Research & Development Medical research

Cannabinoids on the Brain?

Exploring cannabis use in neurological disorders in two very different ways

Testing & Processing Cannabinoid analysis

What's the Deal with Synthetic CBD?

| Richard O’Halloran

The future of cannabinoid manufacture lies not in natural plants but in chemical... plants

Business & Profession Legislation & policy

Don't Cross the Streams!

| Miguel Fagundes

We need a clearer distinction between medicinal, medical, and pharmaceutical cannabis products

Business & Profession Education

We Don’t Need No Education?

If you're a UK-based healthcare professional seeking (free, CPD-accredited) medical cannabis courses, seek no more

Testing & Processing Mycotoxin analysis

Special Series: Keeping Cannabis Consumers Safe

Download our free e-book on safety testing for pesticides, heavy metals, mycotoxins, and more

Testing & Processing Cannabinoid analysis

Sampling Standards: The Unspoken Truth

| Mathias Plourde

Sampling is an integral aspect of the cannabis testing process; indeed, it is critical to the validity and comparability of all laboratory results

Testing & Processing Cannabinoid analysis

Cultivating Innovation

Plant biologist Mark Lange on the astonishing diversity of terpenes

All Articles

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine